Acute coronary syndrome
Therapeutic area
Cardiology
Rare disease
No
- Definition
- Signs and symptoms related to acute ischemia of the myocardium secondary to coronary artery disease. The clinical presentation covers a spectrum of heart diseases from unstable angina to myocardial infarction.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Acute coronary syndrome
- Therapeutic area
- Cardiology
- acute coronary syndrome
- acute coronary syndrome
- acute coronary syndromes
- coronary syndrome, acute
- coronary syndromes, acute
- syndrome, acute coronary
- syndromes, acute coronary
- Disease mechanisms
- Syndromic
- Severity
- Severe
- Cardiology
- Vascular Medicine
- MONDO ID
- MONDO:0005542
- Parent condition
- MONDO:0002254
Related records
Broader conditions (11)
- Acute disease
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Heart disorder
- Human disease
- Ischemic disease
- Myocardial disorder
- Myocardial ischemia
- Syndromic disease
- Vascular disorder
Trials (1,444)
- 'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians
- "Me and My Heart" Study
- "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
- "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
- "SVEAT" Chest Pain Scoring System
- 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
- 18F-NaF-PET for Identification of TCFA
- 2D Strain Echocardiography for Diagnosing Chest Pain in the Emergency Room
- 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS
- 5th Generation cTnT in ED ACS
- 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
- A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)
- A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.
- A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI
- A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
- A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
- A Clinical Trial of IntensiVE Dialysis
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor
- A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
- A Cohort of Patients Undergoing Percutaneous Coronary Intervention
Approved drugs (11)
- Bivalirudin
- Cangrelor tetrasodium
- Clopidogrel besilate
- Clopidogrel bisulfate
- Clopidogrel hydrobromide
- Clopidogrel hydrochloride
- Eptifibatide
- Prasugrel besylate
- Prasugrel hydrochloride
- Rivaroxaban
- Ticagrelor
Drugs in development (61)
- Aliskiren Phase 2
- Apixaban Phase 3
- Aspirin Phase 3
- Atopaxar Phase 2
- Atopaxar hydrobromide Phase 2
- Atorvastatin Phase 3
- Atreleuton Phase 2
- Atuliflapon Phase 2
- Bisoprolol fumarate Phase 2
- BMS-919373 Phase 1
- Cangrelor Phase 2
- Citalopram Phase 1
- Clopidogrel Phase 3
- Colchicine Phase 2
- Dalcetrapib Phase 3
- Darapladib Phase 3
- Darexaban Phase 2
- Enoxaparin sodium Phase 1
- Everolimus Phase 1
- Evolocumab Phase 3
Other linked drugs (5)
- Adenosine diphosphate
- Anistreplase
- Dalteparin sodium
- Isosorbide dinitrate
- ST. JOHN'S WORT